CD4 Monoclonal Antibody(11A1)

This gene encodes a membrane glycoprotein of T lymphocytes that interacts with major histocompatibility complex class II antigenes and is also a receptor for the human immunodeficiency virus. This gene is expressed not only in T lymphocytes, but also in B cells, macrophages, and granulocytes. It is also expressed in specific regions of the brain. The protein functions to initiate or augment the early phase of T-cell activation, and may function as an important mediator of indirect neuronal damage in infectious and immune-mediated diseases of the central nervous system. Multiple alternatively spliced transcript variants encoding different isoforms have been identified in this gene.

Introducing the CD4 Monoclonal Antibody (11A1), a cutting-edge product designed to revolutionize the field of immunology. This highly advanced antibody is meticulously engineered to specifically target and bind to the CD4 antigen, a crucial cell surface marker found on T-helper lymphocytes.

Crafted with utmost precision and utilizing state-of-the-art technology, the CD4 Monoclonal Antibody (11A1) offers unparalleled specificity and sensitivity in detecting and quantifying CD4-positive cells. Its exceptional affinity ensures reliable and accurate results, making it an indispensable tool for researchers and clinicians alike.

With its exceptional performance, the CD4 Monoclonal Antibody (11A1) opens up new avenues for studying immune responses, monitoring disease progression, and evaluating therapeutic interventions. Its versatility extends to a wide range of applications, including flow cytometry, immunohistochemistry, and immunofluorescence, enabling comprehensive analysis of CD4 expression in various biological samples.

Furthermore, the CD4 Monoclonal Antibody (11A1) boasts exceptional stability and reproducibility, ensuring consistent and reliable results across experiments. Its robust formulation guarantees long shelf life, allowing for extended usage without compromising performance.

In summary, the CD4 Monoclonal Antibody (11A1) represents a breakthrough in immunological research, offering unmatched specificity, sensitivity, and versatility. With its exceptional performance and reliability, this antibody is poised to revolutionize the field, empowering scientists and clinicians to unravel the complexities of the immune system and pave the way for innovative diagnostic and therapeutic approaches.